TRCT
SHPH icon

Tower Research Capital (TRC)’s Shuttle Pharmaceuticals SHPH Stock Holding History

Tower Research Capital (TRC)’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26K Sell
389
-75
-16% -$491 ﹤0.01% 4856
2026
Q1 		$3.15K Buy
464
+383
+473% +$5.19K ﹤0.01% 4360
2025
Q4 		$1.46K Sell
81
-21
-21% -$537 ﹤0.01% 4692
2025
Q3 		$3.6K Buy
102
+90
+750% +$3.37K ﹤0.01% 4480
2025
Q2 		$463 Sell
12
-2
-14% -$120 ﹤0.01% 5018
2025
Q1 		$1.32K Sell
14
-13
-48% -$2.11K ﹤0.01% 4736
2024
Q4 		$5.89K Buy
27
+12
+80% +$3.12K ﹤0.01% 4226
2024
Q3 		$5.13K Buy
+15
New +$9.2K ﹤0.01% 4324
2024
Q2 		– Hold
0
– – – 5423
2024
Q1 		– Hold
0
– – – 5653
2023
Q4 		– Hold
0
– – – 5777
2023
Q3 		– Hold
0
– – – 5769

Other funds holding SHPH

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Tower Research Capital (TRC)'s SHPH Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Shuttle Pharmaceuticals (SHPH) stake by 16% in Q2 2026, selling an estimated $491 and leaving 389 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #4856.

Tower Research Capital (TRC) first reported a position in SHPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.89K in Q4 2024. 5 funds tracked by Wall St. Rank hold SHPH as of Q2 2026.

  • Tower Research Capital (TRC) held 389 shares of Shuttle Pharmaceuticals worth $1.26K as of Q2 2026.
  • Tower Research Capital (TRC) sold 75 Shuttle Pharmaceuticals shares in Q2 2026, an estimated $491.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4856 holding.
  • Tower Research Capital (TRC) first reported a position in Shuttle Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Shuttle Pharmaceuticals position peaked at $5.89K in Q4 2024.
  • 5 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.